Author:
Long Aidan,Rahmaoui Abdelkader,Rothman Kenneth J.,Guinan Eva,Eisner Mark,Bradley Mary S.,Iribarren Carlos,Chen Hubert,Carrigan Gillis,Rosén Karin,Szefler Stanley J.
Subject
Immunology,Immunology and Allergy
Reference22 articles.
1. Novartis US, Genentech. Omalizumab (Xolair) prescribing information. July 2010. Available at: http://www.gene.com/download/pdf/xolair_prescribing.pdf. Accessed February 26, 2014.
2. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics;Soler;Eur Respir J,2001
3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001
4. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma;Holgate;Clin Exp Allergy,2004
5. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma;Bousquet;Allergy,2005
Cited by
188 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献